StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Jefferies Outlines CVS Health (CVS) COVID Vaccine Opportunity, Reiterates $90 PT
January 15, 2021 8:48 AM
Jefferies analyst Brian Tanquilut reiterated a Buy rating and $90.00 price target on CVS Health (NYSE: CVS) noting that investor ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Comments